Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancer

Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancer

View Publication

by Craig Terrones

The Dysregulated Pharmacology of Clinically Relevant ESR1 Mutants is Normalized by Ligand-activated WT Receptor

The Dysregulated Pharmacology of Clinically Relevant ESR1 Mutants is Normalized by Ligand-activated WT Receptor

View Publication

by Craig Terrones

Lasofoxifene in Postmenopausal Women with Osteoporosis

Lasofoxifene in Postmenopausal Women with Osteoporosis

View Publication

by Craig Terrones